A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
Actym Therapeutics, Inc.
Actym Therapeutics, Inc.
Eli Lilly and Company
Telix Pharmaceuticals (Innovations) Pty Limited
Eli Lilly and Company
Elevation Oncology
Hoffmann-La Roche
Stanford University